Spacer
Discovery and translation of the S100A1-based heart failure therapy
Posted October 17 2017
BIOspective - M. Sc. Molecular Bioscience is hosting Prof. Dr. Most who will give a talk on the "Discovery and translation of the S100A1-based heart failure therapy - an unexpected personal and professional journey". Venue: SR041 BioQuant Date and Time: October 30, 2017, 6 p.m.

In the fourth installment of BIOspective Prof. Most will give a talk about how he founded the start-up InoCard. From a scientific concept for gene therapy for heart failure to a therapy now available for acute heart failure he will talk about the pitfalls of medical product development, setting up your own patents, and other critical steps when following the path of a founder. For this we would like to invite you to the next talk October 30th in SR041 of the BioQuant at 6 pm.

 

 

Contact details:

biospective [ aT ] gmx.de

http://www.bio.uni-heidelberg.de/fakultaetbio/en/molbio_news